DCF — BERKSHIRE MEDICAL CENTER
Enterprise Value: $-1.0B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.0B
Enterprise Value
$-325.0M
PV of Cash Flows
$-714.2M
PV of Terminal Value
$-1.2B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $538.6M | $-66.8M | -12.0% | $-89.6M | $-81.4M |
| Year 2 | $554.7M | $-63.2M | -11.0% | $-86.7M | $-71.7M |
| Year 3 | $571.4M | $-59.4M | -10.0% | $-83.6M | $-62.8M |
| Year 4 | $588.5M | $-58.3M | -10.0% | $-83.2M | $-56.8M |
| Year 5 | $606.2M | $-58.5M | -10.0% | $-84.2M | $-52.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.0B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$522.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12901356465685557
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5